|
Spironolactone and Hydrochlorothiazide
|
|
Aldactazide
|
Spironolactone and Hydrochlorothiazide Clinical Trials
- Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
Hypertension
- Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
Hypertension
- Safety and Efficacy of Larger Dose of Spironolactone for the Treatment of Patients with Nonischemic Cardiomyopathy
ClinicalTrials.gov Identifier: NCT00125437 - Recruiting
Heart Failure, Congestive
- Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00387517 - Active, not recruiting
Hypertension
- Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00500604 - Recruiting
Hypertension
- A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00153049 - Completed
Hypertension
- Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
Hypertension
- Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
ClinicalTrials.gov Identifier: NCT00394394 - Completed
Hypertension
- A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison with Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients with Mild to Modera
ClinicalTrials.gov Identifier: NCT00133185 - Completed
Hypertension
- Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
Hypertension
- Spironolactone Safety in Dialysis Patients
ClinicalTrials.gov Identifier: NCT00328809 - Recruiting
End Stage Renal Disease; Congestive Heart Failure
- Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
ClinicalTrials.gov Identifier: NCT00282178 - Active, not recruiting
Hypertension; Obesity
- Clinical Trial Studying the Effects of Spironolactone on Heart and Skeletal Muscle Function in Chronic Alcoholics
ClinicalTrials.gov Identifier: NCT00226109 - Recruiting
Cardiomyopathy, Alcoholic; Alcoholism
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
Hypertension
- Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
Hypertension
- Spironolactone in Patients With Single Ventricle Heart
ClinicalTrials.gov Identifier: NCT00211081 - Active, not recruiting
Single Ventricle
- A Clinical Study to Evaluate the Long-Term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
ClinicalTrials.gov Identifier: NCT00171405 - Active, not recruiting
Hypertension
- Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
ClinicalTrials.gov Identifier: NCT00276289 - Recruiting
Idiopathic Hypercalciuria; Hypokalemia Caused by Thiazide Diuretics
- Cardiovascular Protective Effect of Spironolactone in Hemodialysis
ClinicalTrials.gov Identifier: NCT00277693 - Recruiting
Hemodialysis
- A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
Hypertension; Diabetes
- Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
ClinicalTrials.gov Identifier: NCT00360178 - Completed
Hypertension
- PIE II: Pharmacological Intervention in the Elderly II
ClinicalTrials.gov Identifier: NCT00123955 - Active, not recruiting
Diastolic Heart Failure
- Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
ClinicalTrials.gov Identifier: NCT00443612 - Recruiting
Hypertension
- A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
ClinicalTrials.gov Identifier: NCT00168779 - Completed
Hypertension
- Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
ClinicalTrials.gov Identifier: NCT00232882 - Recruiting
Hypertension
- Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
Essential Hypertension
- Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
ClinicalTrials.gov Identifier: NCT00335413 - Not yet recruiting
Hypertension
- A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
Hypertension
- A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
Metabolic Syndrome; Hypertension; Pre-Hypertension
- Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
Hypertension; Hypertrophy, Left Ventricular
- Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
Hypertension
- Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
ClinicalTrials.gov Identifier: NCT00487123 - Recruiting
Hypertension
- Addition of Spironolactone in Patients With Resistant Arterial Hypertension
ClinicalTrials.gov Identifier: NCT00524615 - Not yet recruiting
Hypertension
- The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00459056 - Recruiting
Abdominal Obesity; Hypertension
- Is Spironolactone Safe and Effective in the Treatment of Cardiovascular Disease in Mild Chronic Renal Failure?
ClinicalTrials.gov Identifier: NCT00291720 - Recruiting
Chronic Kidney Disease; Cardiovascular Disease
- The Efficacy of Spironolactone in Patients With Resistant Hypertension
ClinicalTrials.gov Identifier: NCT00430794 - Not yet recruiting
Hypertension
- RAAS, Inflammation, and Post-Operative Atrial Fibrillation - Specific Aim 3
ClinicalTrials.gov Identifier: NCT00141778 - Recruiting
Atrial Fibrillation
- Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss
ClinicalTrials.gov Identifier: NCT00175617 - Recruiting
Female Pattern Hair Loss
- Using the Drug Spironolactone to test if it Reduces Protein Leakage from the Kidney
ClinicalTrials.gov Identifier: NCT00106561 - Completed
Kidney Disease; Diabetic Nephropathy; Glomerulonephritis; Proteinuria
- Losartan vs. Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
ClinicalTrials.gov Identifier: NCT00388388 - Recruiting
Pre-Hypertension; Pre-Diabetes
- A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
ClinicalTrials.gov Identifier: NCT00240474 - Completed
Hypertension
- Aldosterone Antagonism in Diastolic Heart Failure
ClinicalTrials.gov Identifier: NCT00108251 - Recruiting
Congestive Heart Failure
- Hydrochlorothiazide (+) Losartan Potassium Vs. Amlodipine Comparative Study
ClinicalTrials.gov Identifier: NCT00157963 - Completed
Essential Hypertension
- Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
ClinicalTrials.gov Identifier: NCT00267943 - Completed
Hypertension
- Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00139698 - Completed
Essential Hypertension
- Phase II Study of the Effect of Leuprolide Acetate and Spironolactone on Insulin Resistance in Hyperandrogenic Women with Polycystic Ovarian Disease or Hyperandrogenism Insulin Resistance Acanthosis Nigricans Syndrome
ClinicalTrials.gov Identifier: NCT00004311 - Completed
Acanthosis Nigricans; Polycystic Ovary Syndrome
- Left Ventricular Hypertrophy and Spironolactone in End Stage Renal Disease
ClinicalTrials.gov Identifier: NCT00548912 - Completed
Kidney Failure, Chronic
- Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00430508 - Not yet recruiting
Essential Hypertension
- Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
Essential Hypertension
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
ClinicalTrials.gov Identifier: NCT00263393 - Recruiting
* Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
- An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hy
ClinicalTrials.gov Identifier: NCT00449111 - Terminated
Hypertension
- Spironolactone Combined With Captopril and Carvedilol for the Treatment of Pulmonary Arterial Hypertension
ClinicalTrials.gov Identifier: NCT00240656 - Completed
Hypertension, Pulmonary
- Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
Heart Disease
- Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
ClinicalTrials.gov Identifier: NCT00171561 - Completed
Hypertension
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
ClinicalTrials.gov Identifier: NCT00170989 - Completed
Hypertension
- Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
ClinicalTrials.gov Identifier: NCT00355589 - Completed
Hypertension; Blood Pressure, High
- Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
ClinicalTrials.gov Identifier: NCT00367094 - Completed
Hypertension
- Spironolactone for Reducing Proteinuria in Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00498537 - Completed
Diabetic Nephropathy
- Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
ClinicalTrials.gov Identifier: NCT00219037 - Completed
Hypertension
- A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
ClinicalTrials.gov Identifier: NCT00241007 - Completed
Hypertension
- Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
ClinicalTrials.gov Identifier: NCT00273299 - Completed
Hypertension
- Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
ClinicalTrials.gov Identifier: NCT00219024 - Completed
Hypertension
- Treatment of Boys with Precocious Puberty
ClinicalTrials.gov Identifier: NCT00001202 - Completed
Precocious Puberty
- A Clinical Study to Compare Long-Term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
ClinicalTrials.gov Identifier: NCT00294710 - Completed
Hypertension
- Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
ClinicalTrials.gov Identifier: NCT00185120 - Completed
Hypertension
- Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00263003 - Completed
Hypertension
- Spironolactone in Diabetic Nephropathy
ClinicalTrials.gov Identifier: NCT00317954 - Completed
Diabetic Nephropathy
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
ClinicalTrials.gov Identifier: NCT00095394 - Completed
Hypertension
- Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients with Moderate Hypertension
ClinicalTrials.gov Identifier: NCT00095550 - Completed
Hypertension
- A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
ClinicalTrials.gov Identifier: NCT00386139 - Completed
Hypertension
- Hemodynamic Effects of Chronic Administration of Spironolactone and/or Propranolol in Alcoholic Cirrhotic Patients
ClinicalTrials.gov Identifier: NCT00188045 - Terminated
Alcoholic Cirrhosis
- Olmesartan as an Add-on to Amlodipine in Hypertension
ClinicalTrials.gov Identifier: NCT00220233 - Completed
Essential Hypertension
- Irbesartan in the Treatment of Hypertensive Patients with Metabolic Syndrome
ClinicalTrials.gov Identifier: NCT00110422 - Completed
Metabolic Syndrome X; Hypertension
- A Randomised, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 40 Mg (Micardis®) in Patients Who Fail to Respond Adequately to Treatment with Telmisartan (Micardis®) 40 Mg
ClinicalTrials.gov Identifier: NCT00144222 - Completed
Hypertension
- Diuretics, Hypertension, and Arrhythmias Clinical Trial
ClinicalTrials.gov Identifier: NCT00000525 - Completed
Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Hypertension
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
